Lifecore Biomedical, Inc. (LFCR) vs Alpha Teknova, Inc. (TKNO)

Lifecore Biomedical, Inc. and Alpha Teknova, Inc. are both Drug Manufacturers Specialty & Generic companies. Alpha Teknova, Inc. is the larger, with a market value of $408.0M against $244.1M — 1.7× the size. Alpha Teknova, Inc. grew revenue faster over the last twelve months: 12.3% against −10.0%. Lifecore Biomedical, Inc. has the higher net margin (−37.5% vs −38.4%) and the higher return on invested capital (−2.80% vs −16.9%). Across the 17 metrics below, Alpha Teknova, Inc. leads on 9 and Lifecore Biomedical, Inc. on 8.

Valuation

Metric LFCR TKNO Drug Manufacturers Specialty & Generic median
P/E n/m n/m 19.25
P/S 2.00 8.69 2.11
P/B n/m 6.07 1.78
Price to free cash flow n/m n/m 16.14
EV/EBITDA n/m n/m 12.58
EV/Sales 3.41 8.69 2.73
Earnings yield (15.20%) (4.38%) (4.38%)
Free cash flow yield (2.11%) (1.94%) 0.00%

Profitability

Metric LFCR TKNO Drug Manufacturers Specialty & Generic median
Gross margin 26.86% 34.60% 53.94%
Operating margin (6.89%) (36.19%) 0.00%
Net margin (37.54%) (38.37%) 0.00%
Free cash flow margin (4.24%) (16.83%) 0.00%
Return on equity 201.15% (24.19%) (0.40%)
Return on assets (19.32%) (16.25%) (3.32%)
Return on invested capital (2.80%) (16.93%) 0.00%

Growth

Metric LFCR TKNO Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) (10.03%) 12.27% 10.01%
EPS growth (last fiscal year) (439.33%) 43.86% 49.06%
Revenue growth, 5-year CAGR (4.24%) 5.30% 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LFCR TKNO Drug Manufacturers Specialty & Generic median
Debt to equity 11.50 0.21 0.05
Current ratio 3.87 4.49 2.31
Net debt to EBITDA (15.59) 0.75 0.97

Dividend

Metric LFCR TKNO Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.57%
Payout ratio — — 0.27

Size

Metric LFCR TKNO Drug Manufacturers Specialty & Generic median
Market cap 244.12m 408.03m 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack